| scholarly article | Q13442814 |
| P50 | author | Simon Rosenbaum | Q38544589 |
| Philip B. Ward | Q38544599 | ||
| Brendon Stubbs | Q38545271 | ||
| Fiona Gaughran | Q52280795 | ||
| John Lally | Q56816484 | ||
| Christoph Correll | Q56954221 | ||
| Michel Probst | Q60445330 | ||
| Davy Vancampfort | Q66759492 | ||
| Britta Galling | Q91784092 | ||
| P2093 | author name string | Marc De Hert | |
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 |
| TYPE 2 DIABETES IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A META-ANALYSIS OF PREVALENCE ESTIMATES AND PREDICTORS. | Q38538401 | ||
| Prevalence and predictors of type 2 diabetes mellitus in people with bipolar disorder: a systematic review and meta-analysis | Q38555006 | ||
| Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression | Q39532426 | ||
| Markers of inflammation in schizophrenia: association vs. causation | Q42738765 | ||
| Treatment with antipsychotics and the risk of diabetes in clinical practice | Q42872475 | ||
| Avoidable mortality in people with schizophrenia or bipolar disorder in England | Q45255749 | ||
| Diabetes, physical activity participation and exercise capacity in patients with schizophrenia | Q46197558 | ||
| Antidepressant use and glycemic control. | Q50726991 | ||
| Associations between sedentary behaviour and metabolic parameters in patients with schizophrenia. | Q51358272 | ||
| Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiolog | Q51864697 | ||
| Antipsychotics and diabetes: an age-related association | Q81714647 | ||
| A Systematic Review of Mortality in Schizophrenia | Q22253025 | ||
| Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies | Q24608301 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Operating characteristics of a rank correlation test for publication bias | Q27860653 | ||
| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q27860791 | ||
| Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
| Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial | Q30949176 | ||
| Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association | Q33728882 | ||
| Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London | Q33911053 | ||
| Risks of all-cause and suicide mortality in mental disorders: a meta-review | Q33915499 | ||
| Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis | Q34183529 | ||
| Trends in use of second-generation antipsychotics for treatment of bipolar disorder in the United States, 1998-2009. | Q34245595 | ||
| Mortality in schizophrenia and other psychoses: a 10-year follow-up of the ӔSOP first-episode cohort | Q34440708 | ||
| Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. | Q34623350 | ||
| Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. | Q34631699 | ||
| Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naïve schizophrenia patients | Q34661651 | ||
| Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. | Q35016170 | ||
| Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study | Q35087495 | ||
| Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder | Q35754726 | ||
| Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis | Q36118736 | ||
| Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics | Q36755212 | ||
| The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers | Q36864458 | ||
| A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls | Q37236162 | ||
| Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies | Q37499748 | ||
| Major depressive disorder treatment guidelines in America and Europe | Q37725179 | ||
| Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation | Q37908905 | ||
| International Organization of Physical Therapy in Mental Health consensus on physical activity within multidisciplinary rehabilitation programmes for minimising cardio-metabolic risk in patients with schizophrenia | Q37940519 | ||
| Metabolic and cardiovascular adverse effects associated with antipsychotic drugs | Q37947095 | ||
| The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders | Q37981166 | ||
| Glucose metabolism and antidepressant medication | Q38017266 | ||
| Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis | Q38064833 | ||
| Pharmacologic and behavioral interventions to improve cardiovascular risk factors in adults with serious mental illness: a systematic review and meta-analysis | Q38219710 | ||
| The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis | Q38460789 | ||
| The prevention of diabetes and cardiovascular disease in people with schizophrenia. | Q38482029 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| major depressive disorder | Q42844 | ||
| bipolar disorder | Q131755 | ||
| meta-analysis | Q815382 | ||
| systematic review | Q1504425 | ||
| P304 | page(s) | 166-174 | |
| P577 | publication date | 2016-06-01 | |
| P1433 | published in | World Psychiatry | Q8036083 |
| P1476 | title | Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis | |
| P478 | volume | 15 |
| Q57292778 | Q57292778 |
| Q57292791 | Q57292791 |
| Q90165988 | 'Walk this way': results from a pilot randomised controlled trial of a health coaching intervention to reduce sedentary behaviour and increase physical activity in people with serious mental illness |
| Q86591610 | 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20) |
| Q58722686 | A Cross Sectional Examination of the Relation Between Depression and Frequency of Leisure Time Physical Exercise among the Elderly in Jinan, China |
| Q33617569 | A systematic review of physical activity policy recommendations and interventions for people with mental health problems in Sub-Saharan African countries |
| Q89634257 | Active Commuting and Depression Symptoms in Adults: A Systematic Review |
| Q97425551 | Assessing dietary and lifestyle risk behaviours and their associations with disease comorbidities among patients with depression: A case-control study from Bahrain |
| Q93065943 | Association Between Antipsychotic Medication Use and Diabetes |
| Q93185385 | Association between polymorphisms of LEP, LEPR, DRD2, HTR2A and HTR2C genes and risperidone- or clozapine-induced hyperglycemia |
| Q51246446 | Association of Protein Kinase B (AKT) DNA Hypermethylation with Maintenance Atypical Antipsychotic Treatment in Patients with Bipolar Disorder. |
| Q53439170 | Association of Schizophrenia With the Risk of Breast Cancer Incidence: A Meta-analysis. |
| Q50079662 | Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies |
| Q90011788 | Barriers, attitudes, confidence, and knowledge of nurses regarding metabolic health screening and intervention in people with mental illness: a pilot study from Uganda |
| Q59209509 | Bipolar disorders |
| Q37635208 | Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis |
| Q101133476 | Cardiovascular disease in patients with severe mental illness |
| Q58803192 | Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study |
| Q92187239 | Coping behaviors and depressive status in individuals with type 2 diabetes mellitus |
| Q46781839 | Correlates of physical activity among depressed older people in six low-income and middle-income countries: A community-based cross-sectional study |
| Q36333547 | Depression and physical health multimorbidity: primary data and country-wide meta-analysis of population data from 190 593 people across 43 low- and middle-income countries. |
| Q42327800 | Depressive symptom profiles and glucose tolerance status |
| Q97540224 | Diabetes Mellitus: An Unrecognized Complication in the Management of Patients With Mental Illness |
| Q58760337 | Diet as a hot topic in psychiatry: a population-scale study of nutritional intake and inflammatory potential in severe mental illness |
| Q91581338 | Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people |
| Q87911567 | Disparities in the management of cardiovascular risk factors in patients with psychiatric disorders: a systematic review and meta-analysis |
| Q92492120 | Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial |
| Q59812789 | Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia |
| Q39085510 | Examining methods, messengers and behavioural theories to disseminate physical activity information to individuals with a diagnosis of schizophrenia: a scoping review |
| Q90198639 | Exercise as Medicine for Mental and Substance Use Disorders: A Meta-review of the Benefits for Neuropsychiatric and Cognitive Outcomes |
| Q41628193 | Exercise is medicine for depression: even when the "pill" is small |
| Q92070466 | Focus on Brain Health to Improve Care, Treatment, and Rehabilitation in Forensic Psychiatry |
| Q101564366 | From population to neuron: exploring common mediators for metabolic problems and mental illnesses |
| Q57166465 | Global trends in diabetes complications: a review of current evidence |
| Q58792627 | Glucose and Insulin-Related Traits, Type 2 Diabetes and Risk of Schizophrenia: A Mendelian Randomization Study |
| Q57045656 | Glucose metabolism dysregulation at the onset of mental illness is not limited to first episode psychosis: A systematic review and meta-analysis |
| Q90820905 | High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine |
| Q38712326 | Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder |
| Q39015688 | Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis. |
| Q64103158 | Impaired Glucose Metabolism in Bipolar Patients: The Role of Psychiatrists in Its Detection and Management |
| Q42368732 | Improving life expectancy in people with serious mental illness: should we place more emphasis on primary prevention? |
| Q39281175 | Improving physical health of patients with severe mental disorders: a critical review of lifestyle psychosocial interventions. |
| Q92571505 | Increased Dietary Inflammatory Index Is Associated with Schizophrenia: Results of a Case-Control Study from Bahrain |
| Q47573403 | Increased pericardial adipose tissue and cardiometabolic risk in patients with schizophrenia versus healthy controls. |
| Q92261887 | Insulin resistance and obesity, and their association with depression in relatively young people: findings from a large UK birth cohort |
| Q61807842 | Integrating mental health with other non-communicable diseases |
| Q92697882 | Intensity, frequency, duration, and volume of physical activity and its association with risk of depression in middle- and older-aged Chinese: Evidence from the China Health and Retirement Longitudinal Study, 2015 |
| Q94266240 | Interventions for preventing type 2 diabetes in adults with mental disorders in low and middle income countries |
| Q60545793 | Investigating the Agreement Between Cardiovascular Disease Risk Calculators Among People Diagnosed With Schizophrenia |
| Q99400792 | Investigation of glycaemic traits in psychiatric disorders using Mendelian randomisation revealed a causal relationship with anorexia nervosa |
| Q93092613 | Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities |
| Q90478944 | Lessons Learned From a Physical Activity Intervention in Psychiatric Treatment: Patient, Staff, and Leader Perspectives |
| Q90101980 | Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis |
| Q92549114 | Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial |
| Q64078699 | Mortality rate trends in patients diagnosed with schizophrenia or bipolar disorder: a nationwide study with 20 years of follow-up |
| Q91276821 | Network analysis of the relationship between depressive symptoms, demographics, nutrition, quality of life and medical condition factors in the Osteoarthritis Initiative database cohort of elderly North-American adults with or at risk for osteoarthr |
| Q38947715 | Peer support interventions seeking to improve physical health and lifestyle behaviours among people with serious mental illness: A systematic review |
| Q64068909 | Personality associated with depressive status in individuals with type 2 diabetes mellitus |
| Q38853252 | Physical Activity Levels and Psychosis: A Mediation Analysis of Factors Influencing Physical Activity Target Achievement Among 204 186 People Across 46 Low- and Middle-Income Countries |
| Q60046148 | Physical Health Problems in Psychosis: Is It Time to Consider the Views of Family Carers? |
| Q38814737 | Physical activity and depression: a large cross-sectional, population-based study across 36 low- and middle-income countries. |
| Q89924379 | Physical health among patients with common mental health disorders in primary care in Europe: a scoping review |
| Q29994580 | Physical health policies and metabolic screening in mental health care systems of sub-Saharan African countries: a systematic review |
| Q36200262 | Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries |
| Q51753114 | Physiotherapy for people with mental health problems in Sub-Saharan African countries: a systematic review. |
| Q64119436 | Prediction of Depression Scores From Aerobic Fitness, Body Fatness, Physical Activity, and Vagal Indices in Non-exercising, Female Workers |
| Q90161036 | Prediction of cardiovascular disease risk among people with severe mental illness: A cohort study |
| Q90090312 | Prevalence and major risk factors of type 2 diabetes mellitus among adult psychiatric inpatients from 2005 to 2018 in Beijing, China: a longitudinal observational study |
| Q94544871 | Prevalence of Prediabetes and Diabetes Mellitus Type II in Bipolar Disorder |
| Q55359603 | Primary care access for mental illness in Australia: Patterns of access to general practice from 2006 to 2016. |
| Q38931865 | Prospective associations of exercise and depressive symptoms in older adults: the role of apolipoprotein E4. |
| Q39459343 | Relationship Between Objectively Measured Sedentary Behavior and Cognitive Performance in Patients With Schizophrenia Vs Controls |
| Q33878816 | Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review |
| Q99632782 | Schizophrenia |
| Q61943520 | Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome |
| Q90294208 | Sedentary Behavior and Quality of Life in People with Psychotic Disorders from a Low Income Country: A Study from Uganda |
| Q41658698 | Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis |
| Q92032782 | The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness |
| Q89612657 | The Physical Health Care Fidelity Scale: Psychometric Properties |
| Q90047056 | The Policy Ecology of Behavioral Health Homes: Case Study of Maryland's Medicaid Health Home Program |
| Q38720693 | The association between adolescent psychopathology and subsequent physical activity in young adulthood: a 21-year birth cohort study |
| Q47773183 | The association between physical activity and depression among individuals residing in Brazil |
| Q61451863 | The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials |
| Q96773916 | The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia |
| Q28079065 | Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics |
| Q57797785 | Using the Minnesota Multiphasic Personality Inventory-2-Restructured Form Cutoffs to Predict Lack of Pre-surgical Exercise |
| Q47565684 | Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial |
| Q92451164 | Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial |
| Q64937417 | What Is the Role of Dietary Inflammation in Severe Mental Illness? A Review of Observational and Experimental Findings. |
| Q64991080 | What is the prevalence, and what are the clinical correlates, of insulin resistance in young people presenting for mental health care? A cross-sectional study. |
| Q55023835 | What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? |
| Q89119749 | What prevents youth at clinical high risk for psychosis from engaging in physical activity? An examination of the barriers to physical activity |
| Q89991996 | [Diagnostics and early recognition of bipolar disorders] |
Search more.